Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma, Int J Radiat Oncol Biol Phys, vol.81, pp.623-630, 2011. ,
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, N. Engl. J. Med, vol.352, pp.987-996, 2005. ,
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma, Lancet Oncol, vol.15, pp.395-403, 2014. ,
Angiogenesis in brain tumours, Nat. Rev. Neurosci, vol.8, pp.610-622, 2007. ,
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma, Clin Cancer Res, vol.13, pp.1253-1262, 2007. ,
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma, N. Engl. J. Med, vol.370, pp.709-722, 2014. ,
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma, N. Engl. J. Med, vol.370, pp.699-708, 2014. ,
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF ?, Ann Oncol, vol.25, pp.1442-1449, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01626345
A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party, Br J Cancer, vol.64, pp.769-74, 1991. ,
ESTRO-ACROP guideline "target delineation of glioblastomas, Radiother. Oncol, vol.118, pp.35-42, 2016. ,
Arcthérapie volumétrique modulée du glioblastome près d'organes à risque. Comparaison dosimétrique avec la radiothérapie conformationnelle tridimensionnelle ,
, , vol.18, p.596, 2014.
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group, J. Clin. Oncol, vol.28, pp.1963-1972, 2010. ,
Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma, Oncologist, vol.20, pp.727-735, 2015. ,
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery, N Engl J Med, vol.303, pp.1323-1329, 1980. ,